We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+4.65%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
–
AUM
$208M
AUM Growth
+$8.13M
Cap. Flow
-$386K
Cap. Flow %
-0.19%
Top 10 Hldgs %
70.75%
Holding
559
New
10
Increased
273
Reduced
67
Closed
18

Top Buys

Rank Stock Value
1
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.16M
2
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$1.07M
3
JNK icon
State Street SPDR Bloomberg High Yield Bond ETF
JNK
+$1.02M
4
FM
iShares Frontier and Select EM ETF
FM
+$976K
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$907K

Top Sells

Rank Stock Value
1
IWX icon
iShares Russell Top 200 Value ETF
IWX
+$6.51M
2
IWY icon
iShares Russell Top 200 Growth ETF
IWY
+$6.5M
3
BAC icon
Bank of America
BAC
+$1.1M
4
IEI icon
iShares 3-7 Year Treasury Bond ETF
IEI
+$346K
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$198K

Sector Composition

Rank Sector Weight
1 Financials 3.18%
2 Healthcare 2.1%
3 Technology 2.05%
4 Industrials 1.87%
5 Communication Services 1.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSGX icon
376
Descartes Systems
DSGX
$6.62B
$4K ﹤0.01%
200
– –
EFA icon
377
iShares MSCI EAFE ETF
EFA
$79.4B
$4K ﹤0.01%
74
– –
IMCG icon
378
iShares Morningstar Mid-Cap Growth ETF
IMCG
$4.07B
$4K ﹤0.01%
144
– –
NRG icon
379
NRG Energy
NRG
$24.7B
$4K ﹤0.01%
217
– –
PANW icon
380
Palo Alto Networks
PANW
$297B
$4K ﹤0.01%
222
– –
PUK icon
381
Prudential
PUK
$36.9B
$4K ﹤0.01%
113
-1
-0.9% -$39
VRTX icon
382
Vertex Pharmaceuticals
VRTX
$121B
$4K ﹤0.01%
38
– –
TFCFA
383
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$4K ﹤0.01%
153
– –
DD
384
DELISTED
Du Pont De Nemours E I
DD
$4K ﹤0.01%
57
+12
+27% +$932
MJN
385
DELISTED
Mead Johnson Nutrition Company
MJN
$4K ﹤0.01%
45
-14
-24% -$1.15K
WBK
386
DELISTED
Westpac Banking Corporation
WBK
$4K ﹤0.01%
155
– –
AVY icon
387
Avery Dennison
AVY
$13.3B
$3K ﹤0.01%
48
– –
BNY
388
Bank of New York Mellon
BNY
$107B
$3K ﹤0.01%
84
– –
CCEP icon
389
Coca-Cola Europacific Partners
CCEP
$46.9B
$3K ﹤0.01%
+102
New +$3.56K
CRM icon
390
Salesforce
CRM
$156B
$3K ﹤0.01%
39
– –
DMC
391
Del Monte Corp
DMC
$1.4B
$3K ﹤0.01%
59
-16
-21% -$940
FISV
392
Fiserv Inc
FISV
$29.4B
$3K ﹤0.01%
58
– –
FXB icon
393
Invesco CurrencyShares British Pound Sterling Trust
FXB
$64.6M
$3K ﹤0.01%
29
– –
GD icon
394
General Dynamics
GD
$105B
$3K ﹤0.01%
21
– –
GT icon
395
Goodyear
GT
$2.05B
$3K ﹤0.01%
92
– –
ILCV icon
396
iShares Morningstar Value ETF
ILCV
$1.35B
$3K ﹤0.01%
80
– –
IMCV icon
397
iShares Morningstar Mid-Cap Value ETF
IMCV
$1.16B
$3K ﹤0.01%
72
– –
IP icon
398
International Paper
IP
$22.4B
$3K ﹤0.01%
73
– –
LHX icon
399
L3Harris
LHX
$53.2B
$3K ﹤0.01%
32
– –
MKC icon
400
McCormick & Company Non-Voting
MKC
$14B
$3K ﹤0.01%
62
– –
14 15
16
17 18

Similar funds

TYCC
Texas Yale Capital Corp St. Petersburg, Florida $3.52B AUM 52.63% 1-Year Est. Return
TH
TCTC Holdings Dallas, Texas $3.51B AUM 30.71% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return
BCP
BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Arax Advisory Partners's Q1 2017 Portfolio in Review

As of Q1 2017, Arax Advisory Partners held 559 positions worth $208M, up 4.1% from $200M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Arax Advisory Partners's Q1 2017 filing shows 10 new, 273 increased, 67 reduced and 18 closed positions. Its largest new stake was Thermo Fisher Scientific: 457 shares worth $70K. The largest sale was iShares Russell Top 200 Value ETF, an estimated $6.51M.

By sector, the portfolio is most concentrated in Financials at 3.2% of assets, down from 3.6% a quarter earlier, followed by Healthcare and Technology.

  • Arax Advisory Partners's largest Q1 2017 buy was Thermo Fisher Scientific: 457 shares worth $70K.
  • Arax Advisory Partners added most to Vanguard FTSE Developed Markets ETF in Q1 2017, an estimated $1.16M increase.
  • Arax Advisory Partners's biggest Q1 2017 reduction was iShares Russell Top 200 Value ETF, cutting an estimated $6.51M.
  • Arax Advisory Partners fully exited SRC Energy Inc in Q1 2017, selling an estimated $195K.
  • Arax Advisory Partners's ten largest holdings make up 71% of its $208M portfolio in Q1 2017.
  • Arax Advisory Partners opened 10 new positions and closed 18 in Q1 2017.
  • Arax Advisory Partners's portfolio value rose 4.1% quarter-over-quarter to $208M.

Based on Arax Advisory Partners's 13F filing for Q1 2017, filed 12 May 2017.